Legacy Capital Wealth Partners LLC Sells 1,051 Shares of Chemed Co. (NYSE:CHE)

Legacy Capital Wealth Partners LLC reduced its position in Chemed Co. (NYSE:CHE - Free Report) by 53.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 928 shares of the company's stock after selling 1,051 shares during the quarter. Legacy Capital Wealth Partners LLC's holdings in Chemed were worth $492,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. CWM LLC lifted its holdings in Chemed by 22.2% in the 3rd quarter. CWM LLC now owns 485 shares of the company's stock worth $291,000 after purchasing an additional 88 shares in the last quarter. Creative Planning grew its stake in Chemed by 57.3% during the third quarter. Creative Planning now owns 1,932 shares of the company's stock valued at $1,161,000 after acquiring an additional 704 shares in the last quarter. Net Worth Advisory Group purchased a new stake in Chemed in the 3rd quarter worth $274,000. Blue Trust Inc. boosted its holdings in shares of Chemed by 11.9% during the 3rd quarter. Blue Trust Inc. now owns 1,875 shares of the company's stock valued at $1,127,000 after purchasing an additional 200 shares during the last quarter. Finally, Raymond James & Associates grew its position in shares of Chemed by 4.1% during the third quarter. Raymond James & Associates now owns 75,303 shares of the company's stock valued at $45,255,000 after purchasing an additional 2,993 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $572.77, for a total value of $1,145,540.00. Following the completion of the sale, the chief executive officer now directly owns 101,735 shares of the company's stock, valued at $58,270,755.95. The trade was a 1.93 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Brian C. Judkins purchased 145 shares of the stock in a transaction that occurred on Monday, December 30th. The stock was purchased at an average price of $519.50 per share, with a total value of $75,327.50. Following the acquisition, the vice president now directly owns 1,678 shares of the company's stock, valued at $871,721. This trade represents a 9.46 % increase in their position. The disclosure for this purchase can be found here. Company insiders own 3.32% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a report on Saturday, November 30th. Royal Bank of Canada reduced their target price on shares of Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a report on Tuesday, November 5th.

Chemed Stock Performance

CHE stock traded down $5.45 during mid-day trading on Thursday, reaching $550.19. 107,906 shares of the stock traded hands, compared to its average volume of 88,718. Chemed Co. has a one year low of $512.12 and a one year high of $654.62. The stock has a market capitalization of $8.28 billion, a PE ratio of 27.80, a PEG ratio of 2.15 and a beta of 0.48. The business has a 50-day moving average price of $542.70 and a two-hundred day moving average price of $564.06.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Monday, February 24th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.36%. The ex-dividend date is Monday, February 24th. Chemed's payout ratio is currently 10.11%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.